THE RISK OF LOCAL RECURRENCE IN PATIENTS UNDERGOING NIPPLE – SPARING MASTECTOMY FOR PURE DCIS
There are few studies examining the risk of locoregional recurrence in patients who undergo nipple-sparing mastectomy (NSM) for pure ductal carcinoma in situ (D...
FEATURED, Genetics, Genomics, Research
STUDY SUGGESTS BENEFIT OF DRUG TARGETING PIK3CA-MUTATED BREAST CANCER
Located on chromosome 3, PIK3CA is mutated in approximately 40% of patients with hormone receptor (HR) positive, Her2 negative breast cancer. Standard therapy f...
GARBAGE IN. HOW TO RECOGNIZE A DODGY ACADEMIC JOURNAL
This is a short but excellent article from The Economist. It’s worth a quick read.
AXILLARY LYMPH NODE MICROMETASTASIS
IS THERE STILL A NEED FOR POSTMASTECTOMY RADIATION OR COMPLETION AXILLARY LYMPH NODE DISSECTION?
The Breast Blogatorials
Editor’s comment: It is not the general policy of the Breast Care Network website to plug a commercial endeavor. However, we make an exception in this case for ...
PHENOTYPIC CHARACTERISTICS OF PALB2 RELATED BREAST CANCER
BRCA1 and BRCA2 interact with the PALB2 protein to repair damaged DNA. PALB2 is located on chromosome 16. When located on both alleles, mutations in PALB2 cause...
BILL GATES: THOUGHTS ON THE PANDEMIC
In 2015 Ezra Klein, founder of the Vox Network asked Bill Gates a question. What are you most afraid of? Gates reply is now well known. He was afraid of a flu-l...
40 YEAR TRENDS IN POSTMENOPAUSAL HORMONE THERAPY AND THE INCIDENCE OF BREAST CANCER - DISPARITIES EXIST BETWEEN BLACK AND WHITE WOMEN
The Women’s Health Initiative (WHI) initiated 2 randomized trials in 1993. The trials included conjugated equine estrogen (CEE) in postmenopausal women with a p...
